The structurally related MAPK-activated protein kinases (MAPKAPKs or MKs) MK2, MK3 and MK5 are involved in multiple cellular functions, including cell-cycle control and cellular differentiation. Here, we show that after deregulation of cell-cycle progression, haematopoietic stem cells (HSCs) in MK2-deficient mice are reduced in number and show an impaired ability for competitive repopulation in vivo. To understand the underlying molecular mechanism, we dissected the role of MK2 in association with the polycomb group complex (PcG) and generated a MK2 mutant, which is no longer able to bind to PcG. The reduced ability for repopulation is rescued by re-introduction of MK2, but not by the Edr2-nonbinding mutant of MK2. Thus, MK2 emerges as a regulator of HSC homeostasis, which could act through chromatin remodelling by the PcG complex.
Introduction
Haematopoietic stem cells (HSCs) represent the best-characterized type of adult stem cells. Profound analysis of surface antigens and established protocols to determine the selfrenewal capacity and differentiation make HSCs a favourite model for stem cell biology. The complex microenvironment in the bone marrow regulates the fate of HSCs, controlling the balance between differentiation and self-renewal by providing cytokine and growth factors. However, intracellular signalling pathways involved in HSCs maintenance remain elusive. Recent studies showed controversial roles of evolutionarily conserved signalling pathways such as Smad-, Notch-and Wingless/Int(Wnt)-type (Reya et al, 2003; Duncan et al, 2005; Blank et al, 2006) . The p38 mitogenactivated protein kinase (MAPK) pathway mainly regulates haematopoiesis by myelosuppressive cytokines that inhibit the growth of human primitive haematopoietic progenitors (reviewed in Platanias, 2003) . p38 MAPK was also described to be necessary for erythropoietin expression and erythropoiesis (Tamura et al, 2000) and for thrombopoietin-induced self-renewal and expansion of HSCs through homeobox protein Hoxb4 (Kirito et al, 2003) . More recently, the involvement of p38 MAPK in oxidative stress-elicited HSC depletion was shown (Ito et al, 2006) . However, redundancy in these signalling pathways as well as the early embryonic lethality of most knockout mouse models makes the systemic analysis of the involvement of these pathways still puzzling.
The three MAPKAP kinases (MKs), MK2, MK3 and MK5, are involved in the regulation of inflammatory-cytokine production, in rearrangement of the cytoskeleton and cell migration, in cell-cycle checkpoint control, in developmental regulation, as well as in chromatin repression and remodelling (reviewed in Gaestel, 2006) . Whereas the regulatory function of MKs in cytokine production is well known (Kotlyarov et al, 1999; Winzen et al, 1999) , their role in controlling chromatin repression and remodelling remains elusive. Recent evidence indicates that polycomb group proteins may be targets for MK2 (Yannoni et al, 2004) and MK3 (Voncken et al, 2005) . The polycomb group family, originally identified in Drosophila melanogaster as a repressor of homeotic genes, represents epigenetic chromatin modifiers with transcriptional silencing function (Zink and Paro, 1989; Valk-Lingbeek et al, 2004) . In Drosophila and mammals, two cooperating PcG complexes have been identified (Lund and van Lohuizen, 2004) . The polycomb repressive or initiation complex (PRC2), which shows histone-modifying activity, cooperates with the polycomb maintenance complex (PRC1), which interacts with modified histones to repress the expression of genes (Levine et al, 2004) , such as the developmental regulators in murine embryonic stem cells (Boyer et al, 2006) . In humans, PRC1 is a multiprotein complex including the human polycomb proteins HPC1-3, core proteins such as RING1A, RING1B, BMI1, as well as the early development regulator/human polyhomeotic EDR1/ HPH1 and EDR2/HPH2. PcG proteins can interact with a series of additional molecules to exert control on gene expression in a highly regulated and dynamic manner (reviewed in Lund and van Lohuizen, 2004) .
A crucial role of PRC1 and its individual components has been shown by analysis of mice with targeted deletion of mouse homologues of BMI1 (Bmi1), EDR1/HPH1 (Edr1/Mph1/Phc1/Rae28) and EDR2/HPH2 (Edr2/Mph2/ Phc2). Bmi1-deficient mice are characterized by progressive loss of HSCs and cerebellar neurons (van der Lugt et al, 1994) . More recently, direct evidence implicated Bmi1 in the self-renewal of stem cells (Lessard and Sauvageau, 2003; Molofsky et al, 2003; Park et al, 2003) . Similarly, Mph1/ Rae28-deficient HSCs show decreased proliferative and selfrenewal capacity (Ohta et al, 2002; Park et al, 2003) . In addition to defects in the homeostasis of HSCs, PRC1 and PRC2 PcG mutant mice also suffer from lymphoid differentiation defects (reviewed in Valk-Lingbeek et al, 2004) and, in case of Phc2/Edr2, from changes in skeleton and premature senescence (Isono et al, 2005) . Thus, PcG proteins play a crucial role in regulating stem cell self-renewal and differentiation (recently reviewed in Rajasekhar and Begemann, 2007) .
In vitro evidence indicates that MK2 and MK3 may selectively interact with EDR2/HPH2 and target components of PRC1 (Yannoni et al, 2004; Voncken et al, 2005) , suggesting a functional link between MAPKAP kinases and polycomb proteins. Here, we analyse the interaction between mouse PRC1 and MK2 and unequivocally document a role for the MK2 complex in maintaining the 'stemness' of HSCs in vivo.
Results

Phenotypic characterization of haematopoietic stem cells of MK2À/À mice
To numerically assess HSCs, we first quantified the Lin-(CD3eÀ, CD11bÀ, B220À, Gr-1À, TER119À)-Sca1 þ c-Kit þ (LSK) population, classically defined as the HSC compartment. Compared with wild-type mice cells, LSK cells appeared to have increased in relative and absolute numbers in MK2À/À mice ( Figure 1A and B ). As LSK cells contain LT-HSC, ST-HSC, ELPs and multipotent progenitors, we also analysed HSCs defined by expression of SLAM family receptors (Kiel et al, 2005) . As shown in Figure 1B and C, MK2À/À mice showed a decrease in CD150 þ CD48À cells compared with wild-type control mice. Furthermore, upon staining total bone marrow with the Hoechst dye 33342, MK2À/À mice showed a five-fold reduction in side population (SP) cells, known to contain quiescent HSC (Goodell et al, 1996) ( Figure 1D ). LSK cells were further analysed for expression of CD34 and Flt3 to differentiate long-term (LT) (CD34ÀFlt3À)-, short-term (ST) (CD34 þ Flt3À)-HSCs and multipotent progenitor cells (MPPs)(CD34 þ Flt3 þ ). The relative proportion and absolute number of LT-HSCs are decreased in MK2À/À mice whereas these values are increased for MPPs ( Figure 1E and F). To assess whether the lack of MK2 has any effects on the differentiation of HSC, we analysed erythroid, myeloid, and lymphoid cells in the bone marrow and spleen. In consistence with the results published earlier (Kotlyarov et al, 1999) , the proportions of TER119, CD11b and Gr1 were not different between MK2À/À and control mice; furthermore, no differences were seen in phenotypic studies characterizing common lymphoid and myeloid progenitor cells ( Supplementary Figures 1-5 ). In addition, by blood cell count we could not detect a haematopoietic failure in 4-, 8-and 12-months old mice, thus confirming data published earlier (Hegen et al, 2006; Jagavelu et al, 2007) . These findings indicate that the HSC pool is significantly reduced in MK2À/À mice, whereas differentiation of HSCs and progenitor cells is not affected.
Functional characterization of MK2-deficient HSC
We hypothesized that inefficient PcG-mediated transcriptional repression may lead to a release of the actively maintained state of quiescence in HSC. This, in turn, should be associated with increased proliferative responses of HSCs to cytokines. To directly measure the HSC proliferation, we isolated LSK cells from wild-type and MK2À/À mice and cultured them in the presence of a recombinant cytokine cocktail consisting of SCF, IL3, IL6, Flt3L and TPO. As expected, MK2À/À LSK cells showed a significantly higher proliferative response as assessed by 3 H-thymidine incorporation ( Figure 2A ). We were also interested in monitoring the proliferation of different HSC sub-populations in the absence of cytokine stress in vivo. MK2À/À and wild-type mice were fed with BrdU for 48 h, and the BrdU incorporation into LSK cells was determined by FACS analysis. MK2À/À LT-, ST-HSCs and MPPs showed increased staining for BrdU ( Figure 2B ), indicating that enhanced proliferation of HSC is not only associated with cytokine exposure in vitro but also occurs in the physiological bone marrow environment in vivo.
To further assess a putative state of promoted cell-cycle progression in LSK cells, we carried out cell-cycle analysis using propidium iodide staining of in vitro-cultured LSK cells as well as LSK cells directly prepared from mice. In comparison with wild-type cells, MK2À/À cells showed fewer cells in G1/G0 phase and more cells in S and G2/M phases ( Figure 2C) , thus confirming increased cell-cycle progression in the absence of MK2. Cyclin-dependent kinase inhibitors are important mediators of cell quiescence and serve as checkpoints, restricting cell-cycle transition. P21Cip1Waf1deficient HSCs show impaired self-renewal and increased proliferation (Cheng et al, 2000) . To determine the expression levels of P21Cip1Waf1, we carried out RT-PCR analysis in CD150 þ CD48À HSCs from MK2À/À and wild-type mice. As shown in Figure 2D , MK2À/À CD150 þ CD48À HSCs show decreased abundance of p21Cip1/Waf1 mRNA, a finding in line with accelerated cell cycle progression in MK2À/À cells. Similar findings of decreased p21 mRNA level and increased cell-cycle progression were reported in Gfi1-deficient HSCs (Hock et al, 2004) . To shed light on the molecular mechanism of reduced stem-cell quiescence, we determined expression levels of direct downstream targets of Bmi1, p16Ink4a and p19Arf. In the absence of Bmi1, repression of the Ink4a locus is relieved, resulting in expression of p16Ink4a and p19Arf (Jacobs et al, 1999) . As shown in Figure 2E , MK2-deficient CD150 þ CD48À HSCs show higher expression levels of p19Arf, whereas the expression levels of Ink4a and p27 (Kip1) were comparable to those of wildtype control cells (data not shown).
Cytokine-induced proliferation of HSC in vitro is associated with loss of 'stemness'. We hypothesized that the sequence of events resulting in loss of stemness might occur more rapidly in unrestricted proliferation of MK2-deficient HSC. As no phenotypic marker unequivocally reflects HSC function, we monitored the cell-surface expression of Sca1 as a surrogate parameter for early haematopoietic progenitor activity. CD150 þ /CD48À HSCs from MK2À/À and wild-type mice were sorted ( Figure 3A , upper panel) and cultured in vitro in the presence of the recombinant cytokines SCF, IL3, IL6, Flt3L, and TPO. Immediately after cell sorting, both MK2À/À and wild-type CD150 þ /CD48À HSCs showed an equal pattern of expression of c-Kit and Sca1 ( Figure 3A , middle panel). However, after 3 days in vitro, only between 16-21% of MK2À/À progenitor cells stained positive for Sca1, whereas between 60-75% of wild-type progenitor cells maintained Sca1 expression ( Figure 3A , lower panel and quantification below), suggesting that MK2 is crucial for the maintenance of an early state of differentiation or quiescence. Similar results were obtained for LSK cells (data not shown). To assess whether cytokine-stimulated HSCs showed a skewed differentiation, we analysed the expression of lineage-specific cell surface markers. In comparison to wildtype cells, a larger fraction of MK2-deficient cells showed expression of CD11b and Gr1 ( Supplementary Figures 6 and 7) . Analysis of CD150 þ /CD48À HSCs using a CFSE dilution assay indicates higher proliferation of MK2-deficient cells ( Figure 3B ) similar to LSK cells (Figure 2A -C).
The in vitro culture system described above allowed us to test whether a direct inhibitor of p38 MAPK signalling similarly unleashes HSC quiescence. Wild-type LSK cells were purified and incubated for 48 h in the absence or presence of 5 mM SB239063, which does not reduce the overall viability of the cells (Supplementary Figure 8 ). As shown in Figure 3C , cells exposed to a specific p38 inhibitor almost completely lost the expression of Sca1, whereas cells stimulated in the absence of SB239063 remained largely positive for expression of Sca1. These findings corroborate the idea that p38 signalling is crucial for the maintenance of HSC quiescence. The in vivo-proliferation potential of CD150 þ CD48À cells, LT-HSCs, ST-HSCs and MPPs in MK2 þ / þ and MK2À/À mice was measured after feeding BrdU through drinking water for 2 days. RBC-depleted BM cells were stained with monoclonal antibodies recognizing subsets of HSCs and BrdU (negative controls of cells from mice fed with PBS are shown as insets in light grey). Indicated HSC subsets were pre-gated and histograms were generated for quantifying the incorporated BrdU (% of BrdU-positive cells is given). Data are representative of two independent experiments. Cells from three mice from each of the two experiments were measured separately (N ¼ 6). Mean and statistics are in the diagram given below (asterisks indicate significant differences with Po0.05). To directly assess the self-renewal capacity of HSC, we carried out competitive repopulation experiments. Various numbers of wild-type and MK2À/À bone marrow cells (CD45.2) were mixed with 10 5 wild-type CD45.1 competitor cells and transplanted into lethally irradiated CD45.1 recipient mice. Three months later, the mice were killed and the specific contribution of CD45.1 and CD45.2 cells to haematopoiesis was assessed by FACS analysis. In line with earlier experiments (Kotlyarov et al, 1999) and the data shown in Supplementary Figures 1-5, no defect of differentiation in various haematopoietic lineages could be observed in mice transplanted with MK2À/À cells (data not shown), confirming that MK2 is not crucially involved in controlling HSC differentiation. When 10 5 HSCs were mixed with 10 5 competitor cells, MK2-deficient cells contributed to 54% of haematopoiesis, whereas wild-type cells contributed to 75% of haematopoiesis. However, under limiting conditions, when fewer HSCs were transplanted, the statistically significant p38 MAPK/MK2 signalling in self-renewal of HSCs J Schwermann et al difference between MK2-deficient cells and wildtype cells was striking (0.005 versus 29% for 10 4 HSCs and 0.005 versus 0.17% for 10 3 HSCs) ( Figure 3D ). Hence, MK2À/À HSCs showed an obvious disadvantage in their repopulation capacity, when compared with wild-type cells. To confirm and to further extend this finding, the repopulation experiment was also carried out with the LSK cell fraction enriched in HSCs. A similar defect was observed with respect to the LSK-repopulation capacity of MK2À/À cells ( Figure 3E ). We also carried out a secondary transplant experiment to confirm the selfrenewal capacity of HSCs. Mice transplanted with a cell population of 2 Â10 6 WT and MK2À/À bone marrow cells (CD45.2) mixed with 10 5 competitor cells showed a mild reduction of CD45.2-positive MK2À/À cells compared with WT cells 12 weeks after transplantation ( Figure 3F , primary recipients). When 2 Â10 6 bone marrow cells of these primary recipients were transplanted into secondary recipients, a defect of MK2À/À HSC became manifest (32% CD45.2 MK2À/À cells versus 78% CD45.2 MK2 þ / þ cells) ( Figure 3F , secondary recipients), almost independently of addition of wild-type competitor cells (Supplementary Figure  9 ). Finally, the restoration of the CD150 þ CD48À HSC compartment after transplantation into WT mice, depending on the genotype of the donor cells, was analysed and was shown to be reduced for MK2-deficient donor cells ( Figure 3G ).
Together these experiments show that a decreased quiescent HSC pool in MK2À/À mice results in functional impairment under stress conditions.
Identification of Edr1 and Edr2 as interaction partners of MK2
To identify new interacting proteins for mouse MK2, a yeasttwo-hybrid screen was carried out using a murine day-11embryo brain library. The analysis revealed 27 positive clones: three of them carried cDNAs of the known MK2interaction partner p38a, 17 clones carried 11 different cDNA fragments coding for C-terminal parts of mouse Edr1 (n ¼ 4), p36-Edr2 (n ¼ 6) and p90-Edr2 (Yamaki et al, 2002) (n ¼ 1). Interestingly, all Edr1/2 clones contained a single zinc-finger domain with the FCS signature followed by the region coding for the C-terminal homology domains (HD) II and III. HDII is also known as a sterile alpha motif (SAM) domain that has been shown to self-associate, bind to other SAM domains or form heteromeric interactions with some non-SAM domains of other proteins (Qiao and Bowie, 2005) . The specificity of MK2-Edr1/2 interaction was confirmed by GST-pull-down experiments upon recombinant expression in Escherichia coli, using His-p38a/GST-MK2 interaction as a positive control. As shown in Figure 4A , His-Edr1 and His-Edr2 specifically bind to GST-MK2 but not to GST. In subsequent experiments, we limited our investigations to Edr2 interactions, as ectopic overexpression of Edr1 in mammalian cells was inefficient and available antibodies showed a low degree of specificity. Specific interaction of MK2 with endogenous Edr2 was shown by GST pull-down of endogenous Edr2 from HEK293-T cells transfected with different GST constructs ( Figure 4B ). Although endogenous Edr2 was found to bind to GST-MK2 and to the GST fusion of the structurally closely related MK3, which is expressed in LSK cells at levels comparable to MK2 ( Supplementary Figure 10) , as well as to the PcG member GST-Bmi1-used here as a positive control, GST fusion of the structurally more distant MK5, GST-MK5, was not able to bind Edr2 efficiently. We then extended the analysis of MK2-Edr2 interaction by carrying out co-immunoprecipitation of endogenous MK2 and Edr2 from mouse embryonic fibroblasts ( Figure 4C ). The specificity of the positive signal is shown by inefficient co-immunoprecipitation from lysates of MK2/3-deficient fibroblasts.
MK2 interacts with PRC1
Next, we were interested to know whether MK2 interacts with Edr2 within the physiological PRC1 complex. To this end, we tried to detect another core component of PRC1, the ring finger protein Ring1B, in the protein fraction bound to GST-MK2. As a negative control, we used again a GST-MK5 pull-down. As shown in Figure 4D , MK2, but not MK5, precipitates Ring1B, supporting the notion that MK2 is able to interact with the physiological PRC1 complex. To rule out the possibility that this interaction is because of the ectopic overexpression of the recombinant fusion proteins, we analysed the co-existence of the endogenous proteins in high molecular-weight fractions from lysates of mouse embryonic fibroblasts (MEFs). Lysates were separated by gel filtration and protein fractions were analysed by western blot using antibodies against Ring1B and MK2 ( Figure 4E ). In lysates from wildtype MEFs, co-separation of Ring1B and a small sub-population of MK2 can be detected in a fraction corresponding to a molecular mass of about 1MDa (asterisk). To
show the specificity of the bands for MK2, we repeated this analysis with lysate from MK2-deficient MEFs. Although Ring1B can be detected in the corresponding fraction, the two corresponding bands for MK2 (boxed) are missing. This supports the notion that a sub-population of endogenous MK2 exists in the 1-MDa fraction, reflecting its interaction with endogenous PRC1. This interaction obviously does not include p38 MAPK, as it cannot be detected in the 1-MDa fraction (data not shown).
Edr2 and MK2 co-localize in polycomb bodies characteristic for PRC1 MK2 and p38a exist as a complex in the nucleus of resting cells. Upon activation of the p38 MAPK cascade, MK2 is phosphorylated, activated, and because of de-masking of a nuclear export signal, translocates to the cytoplasm (Ben-Levy et al, 1998; Engel et al, 1998; Neininger et al, 2001) . In view of this finding, we hypothesized that a physiologically relevant nuclear PRC1-MK2 interaction may be released upon activation of the p38 MAPK cascade. First, we analysed the sub-cellular localization of MK2 and Edr2 in quiescent HEK293 cells upon transfection with MK2-YFP and Edr2-CFP fusion constructs. Both proteins showed perfect co-localization in speckles in the nucleus (polycomb bodies), reminiscent of the characteristic distribution pattern of proteins organized in PRC1 complexes such as endogenous Edr1, Edr2, Bmi1 and Ring1B (Suzuki et al, 2002 ) ( Figure 5A ). Second, we visualized stress-dependent translocation of GFP-MK2 in HeLa cells co-transfected with HA-Edr2. In contrast to our hypothesis, arsenite-induced stress activation of the p38 MAPK cascade did not trigger complete translocation of MK2 into the cytoplasm. In strict dependence on Edr2 co-expression, a sub-fraction of MK2 was retained in the polycomb bodies ( Figure 5B ), suggesting that activated MK2 alone or in complex with p38 may also have a physiological function at the nuclear PRC1 (cf. also schematic presentation of Figure 7 ).
Identification of the Edr2-interacting region in MK2
To further dissect the molecular interaction between MK2 and Edr2, we carried out GST-Edr2 pull-down assays using GFP fusion proteins with defined MK2 subdomains. Two regions of the small lobe of the kinase, subdomains I-III (amino acids 29-99) and IV-V (amino acids 97-131), are sufficient to interact with Edr2 ( Figure 6A and B) , indicating that both regions contribute to the interaction. The specific role of these subdomains for interacting with Edr2 was further substantiated using a MK2/MK5 hybrid molecule. When amino acids 38-128 are replaced by the homologous region of MK5, the hybrid molecule no longer binds to Edr2, as shown in pull-down experiments ( Figure 6C ), as well as in the co-localization assay ( Figure 6D ). As these domains do not overlap with the C-terminal docking site for p38a at amino acids 371-375 (Tanoue et al, 2000) , it is possible that MK2, Edr2 and p38 can form a ternary complex at PRC1.
Functional rescue of MK2-deficient HSCs requires Edr2-binding of MK2
Finally, we were interested to determine a direct functional link between the HSC phenotype of MK2À/À mice and the Edr2-binding properties of MK2. To address this issue, we made use of the MK2/5 hybrid molecule, which is unable to p38 MAPK/MK2 signalling in self-renewal of HSCs J Schwermann et al associate with Edr2 (see Figure 6C and D) but maintains full catalytic kinase activity, as shown in MK2/3 double knockout cells ( Figure 6E ). MK2/3 double-knockout embryonic fibroblasts do not display any stress-induced Hsp25 phosphorylation. In contrast, retrovirus-mediated expression of MK2/5 and MK2 yielded a comparable level of Hsp25 phosphorylation upon UV stimulation. Hence, MK2 and MK2/5 are indistinguishable with respect to their kinase activity and differ only in Edr2 binding, allowing the dissection of kinase function from Edr2-mediated effects in the MK2/5 hybrid kinase. We hypothesized that MK2-deficient cells would be reconstituted by MK2 but not by the MK2/5 hybrid kinase with respect to stem-cell fitness. The viral constructs were then used to introduce MK2 and MK2/5 into lineage-marker negative MK2-deficient CD45.2 cells, yielding similar transduction rates (30%) as assessed by expression of the marker gene GFP. 10 4 bi-cistronic expression construct-transduced CD45.2 MK2-deficient LSK cells were mixed with the same number of control GFP-construct-transduced CD45.1 LSK WT competitor cells, transplanted into lethally irradiated CD45.1 recipient mice, which were analysed 3 month later. As seen in Figure 6F , Nuclear extracts from wildtype (WT) and MK2-deficient MEFs (MK2À/À) were applied to FPLC gel filtration using a Superose 6 HR 10/30 column. Proteins from load (L) and fractions were subsequently separated by SDS-PAGE. In both lower panels, an empty lane between load and fractions was cut out from the blot to align corresponding molecular-weight fractions between the analysis of WT (upper panel) and MK2-deficient (lower panel) cells. Ring1B and MK2 were detected by western blot. The approximate size of the native proteins in the chromatographic fractions is indicated on the top. The protein size in SDS-PAGE is indicated left. The Ring1B band and the two MK2-specific bands are indicated at the right of each blot. The bands representing the sub-population of MK2 in the high-molecular-weight fraction are marked by a box with asterisk in the anti-MK2 blot of separation of WT lysate. The corresponding region of separation of MK2-deficient lysate lacking these bands is also boxed. The MK2 antibody decorates also several bands in the lysate of MK2-deficient cells (MK2À/À) probably because of cross-reaction with MK3 and because of non-specific binding. N ¼ 3) ) is significantly increased by re-introduction of MK2 (42 and 49%), but not by the re-introduction of the Edr2 non-binding mutant of MK2, MK2/5 (0.4 and 0.2%). Taken together, this indicates that MK2-Edr2 interaction is essential for LSK repopulation capacity.
Discussion
MK2 is a downstream component of the p38 MAPK signalling cascade with pleiotropic functions. Acting as a protein kinase, MK2 controls the regulation of the actin cytoskeleton (Stokoe et al, 1992; Guay et al, 1997) , stress-dependent small heat-shock protein phosphorylation (Vertii et al, 2006) , and stability and translation of the AU-rich element containing cytokine mRNAs (Neininger et al, 2002; Hitti et al, 2006) . Independently of its catalytic activity, MK2 stabilizes p38a and could act as a shuttling protein, mediating nuclear export of p38a (Ben-Levy et al, 1998) .
Here, we propose a new function for MK2 in maintaining HSC quiescence. This function involves MK2-targeting to PRC-1 through Edr1/2 binding and subsequent modulation of the transcriptional control mechanisms governing HSC (HA-Edr2) . In the absence of HA-Edr2, arsenite treatment ( þ Arsenite) leads to export of evenly distributed GFP-MK2 from the nucleus. In cells overexpressing HA-Edr2 ( þ HA-Edr2), GFP-MK2 accumulates in polycomb bodies already before stress treatment (ÀArs). Upon stress and in the presence of HA-Edr2, MK2 is translocated to the cytoplasm, but a sub-population of MK2 remains in polycomb bodies.
quiescence (summarized in Figure 7 ). This represents a mechanism for attracting signal-transducing protein kinases to specific target genes in mammalian cells as already described for the yeast, S. cerevisiae (Pokholok et al, 2006; Proft et al, 2006) . We document the specific interaction of MK2 and members of PRC1 and define the regions involved in Edr2-MK2 interaction as a SAM domain on Edr2 and subdomains I-V in the small lobe of the kinase. The latter does not overlap with the p38a docking site on MK2, possibly allowing formation of a ternary complex. Recently, the p38 MAPK pathway has been shown to control the lifespan of HSCs (Ito et al, 2006) . Sustained Figure 5B ). (F) Competitive repopulation assay. 1 Â10 4 CD45.1 þ LSK cells transduced with pMMP-IRES-GFP together with 1 Â10 4 CD45.2 þ LSK cells transduced with the different bicistronic constructs indicated at the left were transplanted into recipient mice (CD45.1 þ ) and analysed for repopulation capacity as described. Two characteristic experiments and statistical evaluation (right) (N ¼ 6) are shown. Asterisks indicate significant differences (Po0.01) to vehicle-transduced cells. Transfection efficiency (about 30% for all three constructs) was monitored by GFP-expression. 1998) and, hence, by their reduction at the PRC1, induces loss of 'stemness', similar to our findings in MK2-deficient mice. Thus, our analysis of MK2-deficient HSC may provide a missing link between the stress-induced MAPK pathway and Bmi1controlled HSC maintenance. It has been shown that the protein kinase MK3/3pK, which is closely related to MK2 and shows 75% identity in primary structure, is able to directly phosphorylate His-tagged Bmi1 in vitro at as yet unidentified sites (Voncken et al, 2005) . In light of this observation, the MK2 could directly phosphorylate Bmi1 in vivo, as both enzymes share activators and substrates (Clifton et al, 1996; Ronkina et al, 2007) .
Physiologically, we identified a new role for MK2 in maintaining HSC quiescence. Although we could show that the haematopoietic differentiation program seems to be intact in MK2-deficient cells, we identified a selective deficiency of the HSC compartment, as shown by decreased numbers of HSCs in MK2-deficient mice. Furthermore, we defined an increased fraction of proliferating cells in the early haematopoietic progenitor cell pool as well as increased in vitro proliferation, suggesting that MK2 is needed to put brakes on a state of quiescence by modulating the PRC1 complex. As a consequence of MK2 deficiency, 'stemness' is lost, as the The model of stress -signalling to PRC1: In the nucleus of resting cells, a sub-population of MK2 (and MK3) is associated to PRC1 via specific interaction to Edr2 (and/or Edr1). A distinct, probably more abundant sub-population of MK2 (and MK3) exists in complex with p38a (or p38b). On stimulation of the p38 pathway, p38 is phosphorylated by MKK3 or MKK6 and, in turn, phosphorylates MK2 (and MK3) . As a result of phosphorylation, the p38/MK2 complex becomes unstable (Lukas et al, 2004) , the nuclear export signal of MK2 is unmasked (Neininger et al, 2001; White et al, 2007) and the sub-population of MK2 formerly bound to p38 is exported to the cytoplasm meeting its substrates such as Hsp25 and mRNA-binding proteins as tristetraprolin (TTP) (Hitti et al, 2006) . Activated p38 may partially leave the nucleus (Ben-Levy et al, 1998) , but also remains in the nucleus to phosphorylate transcription factors, such as ATF2 (Raingeaud et al, 1996) or MEF2 (Zhao et al, 1999) , as well as PRC1-bound MK2/3. Activation of PRC-bound MK2/3 by p38 leads to phosphorylation of components of PRC1, such as Bmi1 (Voncken et al, 2005) , and contributes to chromatin remodelling. Black balls symbolize phosphorylations.
p38 MAPK/MK2 signalling in self-renewal of HSCs J Schwermann et al HSC's long-term engraftment and repopulation potential resides predominantly in the G0 fraction (Passegue, 2005) . Mechanistically, we propose that targeting of the MK2 to PRC1 is responsible for the observed effects on HSCs. This idea is supported by our finding that the Edr2-binding domain of MK2 is necessary to rescue the repopulation capacity of MK2À/À LSK cells. Interestingly, it seems that the Edr2non-binding mutant MK2/5 even suppresses repopulation capacity. We speculate that this could be because of the interference with MK3 action, which might, to a certain degree, functionally compensate for the loss of MK2. This idea is supported by the comparable expression of MK2-and MK3-mRNA in LSK cells (Supplementary Figure 10) and comparable Edr2-binding ( Figure 4B ) of both enzymes. However, a detailed analysis of the effects of the MK2/5 mutant in WT cells will be necessary to further substantiate this speculation. Few extrinsic and intrinsic factors have been implicated in controlling HSC maintenance (Suda et al, 2005; Adams and Scadden, 2006) . Bmi1, a component of PRC1, is a crucial molecule in governing 'stemness' of HSC (van der Lugt et al, 1994; Lessard and Sauvageau, 2003; Iwama et al, 2004) and neuronal stem cells (Molofsky et al, 2003) . Interestingly, in contrast to Bmi1-deficient stem cells, the Ink4a locus as a downstream target of Bmi1 (Jacobs et al, 1999; Park et al, 2003) , encoding p16Ink4a and p19Arf under the control of two distinct promoters (Quelle et al, 1995) , is selectively affected in MK2-deficient HSC: Only the expression of p19Arf, a protein involved in p53-dependent apoptosis, is increased. The reason for this selectivity is currently unknown, but it might reflect the difference between Bmi1 deletion and loss of Bmi1 phosphorylation, or a different as-yet unknown function of MK2. Regardless of the molecular mechanism, MK2 emerges as a new important player and potential target to be manipulated in normal and malignant haematopoiesis.
Materials and methods
Mice
Mapkapk2 tm1Mgl mice (C57/Bl6) representing the conventional complete knockout of MK2 (Kotlyarov et al, 1999) were bred and maintained under specific pathogen-free conditions in the central animal facility at Hannover Medical School. In all experiments, age-and sex-matched mice were used at 4-12 weeks of age. All experiments were approved by the institutional review board.
Cell sorting and culture
For in vitro studies, purified SLAM (CD150 þ CD48À) or Lin À Sca1 þ c-kit þ cells from MK2 þ / þ and MK2À/À mice were cultured in IMDM medium supplemented with 10% FCS, 2 mM L-glutamine, 1% penicillin-streptomycin, 1 mM non-essential amino acids, 10 ng/ml rm-IL3, 10 ng/ml rm-IL6, 50 ng/ml rm-SCF, 50 ng/ml and rh-Flt3L (all from Peprotech, Rocky Hill, NJ).
For in vitro proliferation experiments, LSK cells were cultured for 48 h as mentioned above and subsequently pulsed with 1 mCi 3 Hthymidine for 12 h. Incorporated 3 H-thymidine was quantified by scintillation counting.
For p38 inhibitor studies, Lin À Sca1 þ c-kit þ cells from MK2 þ / þ mice were sorted and cultured either in the presence or in the absence of SB239063 (5 mM, Calbiochem) for 72 h.
For cell-cycle analysis, sorted LSK cells were cultured for 48 h in vitro and fixed with ice-cold absolute ethanol for 1 h on ice. Cells were washed, incubated with propidium iodide (0.5 mg/ml, Sigma) and RNase A (5 mg/ml, Qiagen) for 1 h, and analysed by flow cytometry.
Side population (SP) studies SP studies were conducted as described earlier (Goodell et al, 1996) . Briefly, RBC-depleted total bone marrow cells of MK2 þ / þ and MK2À/À mice were re-suspended in pre-warmed DMEM medium containing Hoechst 33342 dye (5 mg/ml, Sigma) either in the presence or in the absence of verapamil (50 mM, Sigma) and incubated for 90 min at 371C. Cells were washed twice with ice-cold HBSS, stained with propidium iodide (2 mg/ml) and analysed by a Moflo cell sorter (DAKO Cytomation, Glostrup, Denmark).
Flow cytometry
Single cell suspensions were analysed by flow cytometry using FACS SCAN or FACS Canto and CELLQuest software, FACS Diva software (BD Biosciences) or FlowJo software (Tree Star, Inc., Ashland, OR). Cell sorting of defined sub-populations was carried out using the Moflo cell sorter with Summit software or FACSAria cell sorter (BD Biosciences). The following monoclonal antibodies (all from BD Pharmingen, San Diego, CA except noted otherwise) were used: CD3e-biotin, CD-4-biotin, CD8-biotin, CD11b-biotin, CD11c-biotin, CD19-biotin, CD48-biotin (eBiosciences, San Diego, CA), CD117-APC, CD150-PE (eBiosciences), B220-biotin, Gr-1biotin, Sca-1-PE and TER119-biotin.
BrdU incorporation
In vivo incorporation of BrdU into LSK cells was assessed using the FITC BrdU Flow kit (BD Pharmingen). After a single intraperitoneal injection of BrdU (Sigma, 1 mg per 6 g of mouse weight), an admixture of 1 mg/ml of BrdU was added to the drinking water for 3 days. Mice were killed, BM cells were prepared and stained with antibodies recognizing lineage, Scal and c-kit markers, and analysed by flow cytometry.
CFSE proliferation assay
For CFSE studies, purified CD150 þ CD48À cells were labeled with 2 mM CFSE (Molecular Probes, Karlsruhe, Germany) in IMDM complete medium at 371C for 10 min. Cells were washed with PBS, cultured as indicated above and analysed by flow cytometry.
RNA isolation and real-time PCR
Total RNA was isolated using commercially available kit systems (Absolutely RNA mini prep kit,Stratagene, La Jolla, CA). cDNA was synthesized using oligo-dT primer and expand reverse transcriptase (Roche). p19 and p21 expression levels were determined by realtime PCR using the primers described in Supplementary data. The PCR reaction was carried out in duplicates using a LightCycler-FastStart DNA Master SYBR Green I kit (Roche) according to the manufacturer's instructions.
Competitive repopulation studies
Defined numbers of (i) RBC-depleted donor (CD45.2) BM or of (ii) LSK cells of 8-week-old MK2 þ / þ and MK2À/À mice or (iii) 10 4 MK2À/À LSK cells transduced with the bicistronic pMMP-IRES viral construct (see below) were mixed with (i) 10 5 competitor bone marrow or (ii) 10 4 competitor LSK cells or (iii) 10 4 LSK cells transduced with the viral GFP-expressing control construct (CD45.1) cells, respectively, and transplanted i.v. into lethally irradiated (10 Gy) congenic recipients (CD45.1). In the LSK repopulation experiments ((ii) and (iii)), 10 5 total-BM-compensatory carrier cells (CD45.1) were added to the cell mixture to create a supportive environment during the initial period after transplantation and to increase the viability of the transplanted animals. The number of stem cells in these compensatory cells is negligibly small compared with the number of stem cells in the LSK populations. Transplanted mice were maintained under specific pathogen-free conditions for 3 months. For secondary transplantation, 2 Â10 6 BM cells were transplanted into lethally irradiated congenic recipients and 12 weeks after transplantation, 2 Â10 6 BM cells were isolated, analysed for CD45.2 derived cells and subsequently transplanted into lethally irradiated congenic secondary recipients. At 16 weeks after transplantation, BM of secondary recipients was analysed for CD45.2-derived cells.
Yeast two-hybrid screen
A mouse-brain library (MY4008AH, MATCHMAKER, Clontech) in strain Y187 (MATa) was mated with pGBKT7-MK2 to identify the interaction partners of mouse MK2. About 2.5 Â10 7 colonies that contained 3.5 Â10 6 independent cDNA clones were screened. Transfections, pull-down and co-immunoprecipitation HEK293-T and HeLa cells were cultured and transfected as described (Schumacher et al, 2004) . For in vitro pull-down assays, a total of 1 Â10 7 transfected HEK293-T cells expressing GST-tagged MK2, MK3, MK5 or Bmi1 were used and GST pull-down was carried out as described (Schumacher et al, 2004) . Bound proteins were analysed by western blot using antibodies against Edr2 or Ring1B (Atsuta et al, 2001) . Alternatively, purified recombinant hexahistidine-tagged Edr1, Edr2 or p38 proteins were incubated with recombinant GST or GST-tagged MK2 protein bound to glutathione Sepharose 4B beads. Binding of His-fusion proteins was detected by western blot using 6x-His antibodies (Clontech). For co-IP, 2 Â10 7 immortalized WT or MK2/3 double-knockout MEFs were lysed in 1.3 ml buffer (50 mM HEPES (pH 7.5), 1% Triton X-100, 10% glycerol, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA). In all 2.5 mg of cell lysate was incubated with 5 ml of MK2 antibody (Cell Signaling3042) overnight at 41C and subsequently incubated with 25 ml of protein G Sepharose (Amersham) for 1.5 h at 41C. Beads were washed five times with cold lysis buffer and western blot was carried out using Edr2 antibody (Atsuta et al, 2001) .
Gel filtration
In total, 4 Â 10 7 immortalized WT or MK2-/-mouse embryonic fibroblasts (Kotlyarov et al, 1999) were lysed in 400 ml lysis buffer (20 mM HEPES pH 7.5, 50 mM KCl, 2 mM MgCl 2 , 0.5% Nonidet P40, 0.5 mM DTT, protease inhibitor cocktail tablet (Roche Diagnostics)) and centrifued at 800 g for 8 min at 41C. Supernatant was removed and the pelleted nuclei were lysed in Buffer A (50 mM HEPES pH 7.6, 250 mM NaCl, 10% glycerol, 0.5% Triton X-100, 1 mM EDTA, 1 mM DTT, protease inhibitor cocktail tablet (Roche Diagnostics)) for 20 min on ice. Nuclei were passed 10 times through a 20-gauge needle and centrifuged at 16 000 g, 41C. In total, 500 mg of nuclear extract was separated by FPLC (LCC-500 Plus) using two Superose 6HR 30/10 columns connected in series (Pharmacia LKB Biotechnology, Uppsala, Sweden), developed with 0.05 M K 2 HPO 4 / KH 2 PO 4 , pH 7.2, 0.15M NaCl with a flow-rate of 0.1 ml/min. Proteins from fractions were precipitated by adding 1/100 volume of 2% deoxycholate, incubation for 30 min at 41C and addition of 1/10 volume of 100% trichloroacetic acid. Samples were incubated overnight at 41C, centrifuged for 15 min at 16 000 g, air-dried, dissolved in 4 Â SDS sample buffer and separated by 10% SDS-PAGE. Western blotting was carried out using anti-Ring1B (Atsuta et al, 2001 ) and anti-MK2 (Cell Signaling 3042) antibodies.
Fluorescence microscopy
For subcellular localization of YFP-and CFP-tagged proteins, the transfected cells (with lipofectamine/plus reagent, Invitrogen) were replated in chambered coverglass (Lab-Tek, Nunc) and analysed using a Leica DM IRBE microscope with the Leica TCS confocal systems program. For immunocytochemistry, HeLa cells were seeded on poly-L-lysine-coated coverslips. At 24 h after transfection of EGFP-and HA-tagged proteins, cells were fixed with 4% paraformaldehyde and incubated overnight with HA antibodies (Santa Cruz, sc-805) followed by Alexa 555 (Invitrogen, A31572) staining.
Cloning, construction of deletion mutants and site-directed mutagenesis Cloning techniques are described in detail in Supplementary data. For generation of deletion mutants, the fusion of amino acids 29-131, 29-99 and 97-131 of MK2 to EGFP was carried out by inserting EcoRI-BamHI-cut PCR fragments, amplified from pEGFP-MK2 (Engel et al, 1995) using the primers given in Supplementary data, into pEGFP-C1 (Clontech). The pEGFP-MK2/MK5 hybrid was generated by deletion of MK2-amino acids 37-131 from pEGFP-MK2 using PstI/SacI and cloning of PstI-SacI-cut PCR fragment of MK5-amino acid 10-110, amplified with the primers given in Supplementary data.
Viral transductions of MEFs and L-negative cells
MEFs were tranduced with the retroviral constructs pMMP-IRES-GFP, pMMP-MK2-IRES-GFP and pMMP-MK2/5-IRES-GFP as described (Ronkina et al, 2007) . pHsp25 was detected by western blotting using an anti-phosphoS86-Hsp25 antibody (BioSource). Before retroviral transduction, L-negative cells were stimulated with mSCF (100 ng/ml), hIL-11 (100 ng/ml) and hFlt3-Lig (100 ng/ml) for 48 h in StemSpan. Lin(À) Ly 5.1 cells were transduced with pMMP-IRES-GFP (MOI ¼ 3) whereas Lin(À) Ly 5.2 were transduced with the different retroviral transfer vectors with MOI ¼ 3 after 48 and 60 h. The Lin(À) transduced cells were sorted for Sca-1 þ c-Kit þ LSK before mixing for repopulation assay.
Supplementary data
Further experimental data, data about plasmids and primers used for cloning and PCR as well as cloning details are provided in the Supplementary data. Supplementary Figures are provided. Supplementary data are available at The EMBO Journal Online (http:// www.embojournal.org).
